Congenital enteropathy due to enteropeptidase deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Congenital enteropathy due to enteropeptidase deficiency.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Clotic

Laboratorios Salvat, S.A.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Clotic

(clotrimazole)Orphan drugstandard

Laboratorios Salvat, S.A.

Azole Antifungal [EPC]

12.1 Mechanism of Action Clotrimazole is an azole antifungal agent [see Microbiology (12.4) ] .

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Congenital enteropathy due to enteropeptidase deficiency.
Search all trials →

Search clinical trials for Congenital enteropathy due to enteropeptidase deficiency →

Recent News & Research

No recent news articles indexed yet for Congenital enteropathy due to enteropeptidase deficiency.
Search PubMed for Congenital enteropathy due to enteropeptidase deficiency →

Browse all Congenital enteropathy due to enteropeptidase deficiency news →

Specialist Network

No specialists currently listed for Congenital enteropathy due to enteropeptidase deficiency.

View all Congenital enteropathy due to enteropeptidase deficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰